Literature DB >> 35221554

Pulmonary sclerosing pneumocytoma-a case series.

Nishok David1, Sujith Thomas Chandy2, Santhosh Regini Benjamin1, Aamir Mohammad1, Sameer Mallampati1, Thomas Alex Kodiatte3, Birla Roy Gnanamuthu1.   

Abstract

Pulmonary sclerosing pneumocytoma (PSP) is a rare and interesting pulmonary tumour that presents a diagnostic challenge to the surgeon due to its bland symptomatology, indolent course, non-specific radiological features and ambiguous histopathological findings, which could lead to errors in management and prognostication. Herein, we present a series of 4 patients with PSP who were managed in our institution over a period of 8 years and briefly discuss relevant literature. © Indian Association of Cardiovascular-Thoracic Surgeons 2021.

Entities:  

Keywords:  Benign or congenital lesions; Carcinoid; Immunohistochemistry; Lung; Sclerosing pneumocytoma; Tumour

Year:  2022        PMID: 35221554      PMCID: PMC8857380          DOI: 10.1007/s12055-021-01269-z

Source DB:  PubMed          Journal:  Indian J Thorac Cardiovasc Surg        ISSN: 0970-9134


  18 in total

1.  Sclerosing hemangioma (histiocytoma, xanthoma) of the lung.

Authors:  A A LIEBOW; D S HUBBELL
Journal:  Cancer       Date:  1956 Jan-Feb       Impact factor: 6.860

2.  The 2015 World Health Organization Classification of Lung Tumors: Impact of Genetic, Clinical and Radiologic Advances Since the 2004 Classification.

Authors:  William D Travis; Elisabeth Brambilla; Andrew G Nicholson; Yasushi Yatabe; John H M Austin; Mary Beth Beasley; Lucian R Chirieac; Sanja Dacic; Edwina Duhig; Douglas B Flieder; Kim Geisinger; Fred R Hirsch; Yuichi Ishikawa; Keith M Kerr; Masayuki Noguchi; Giuseppe Pelosi; Charles A Powell; Ming Sound Tsao; Ignacio Wistuba
Journal:  J Thorac Oncol       Date:  2015-09       Impact factor: 15.609

Review 3.  Sclerosing Pneumocytoma: a Carcinoma Mimicker. A Case Report and Literature Review.

Authors:  Jain Zhou; Michael H Covinsky
Journal:  Ann Clin Lab Sci       Date:  2017-01       Impact factor: 1.256

4.  Clinicopathological analysis of pulmonary sclerosing hemangioma.

Authors:  Akira Iyoda; Kenzo Hiroshima; Mitsutoshi Shiba; Yukiko Haga; Yasumitsu Moriya; Yasuo Sekine; Kiyoshi Shibuya; Toshihiko Iizasa; Takehiko Fujisawa
Journal:  Ann Thorac Surg       Date:  2004-12       Impact factor: 4.330

5.  Pulmonary sclerosing hemangioma consistently expresses thyroid transcription factor-1 (TTF-1): a new clue to its histogenesis.

Authors:  A C Chan; J K Chan
Journal:  Am J Surg Pathol       Date:  2000-11       Impact factor: 6.394

6.  Sclerosing pneumocytoma with metastasis to the mediastinal and regional lymph nodes.

Authors:  Xiaojun Wang; Lizhi Zhang; Yanfu Wang; Xuzhao Jia; Jiali Wang; Hua Zhang
Journal:  Indian J Pathol Microbiol       Date:  2018 Jul-Sep       Impact factor: 0.740

7.  Surgery for Pulmonary Sclerosing Hemangioma: Lobectomy versus Limited Resection.

Authors:  Joon Seok Park; Kwhanmien Kim; Sumin Shin; Hunbo Shim; Hong Kwan Kim
Journal:  Korean J Thorac Cardiovasc Surg       Date:  2011-02-12

8.  Treatment of 28 patients with sclerosing hemangioma (SH) of the lung.

Authors:  Yang Lei; Duan Yong; Ruan Jun-Zhong; Yang Zhi; Wang Zi-Tong
Journal:  J Cardiothorac Surg       Date:  2012-06-18       Impact factor: 1.637

9.  Pulmonary sclerosing pneumocytoma of the lung: CT characteristics in a large series of a tertiary referral center.

Authors:  So Youn Shin; Mi Young Kim; Sang Young Oh; Hyun Joo Lee; Soon Auck Hong; Se Jin Jang; Sung-Soo Kim
Journal:  Medicine (Baltimore)       Date:  2015-01       Impact factor: 1.889

10.  Sclerosing Pneumocytoma: A Ten-Year Experience at a Western Balkan University Hospital.

Authors:  Aleksandra Lovrenski; Milena Vasilijević; Milana Panjković; Dragana Tegeltija; Dejan Vučković; Ilija Baroš; Jovan Lovrenski
Journal:  Medicina (Kaunas)       Date:  2019-01-25       Impact factor: 2.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.